Significance of serum cholesterol and fibrinogen in evaluating the risk of glomerulosc-lerosis in children with nephrotic syndrome

ZHANG Jian-Jiang, FU Shu-Qin, DOU Wen-Jie, SHI Pei-Pei, WANG Miao, TIAN Xi-Yan

Chinese Journal of Contemporary Pediatrics ›› 2014, Vol. 16 ›› Issue (4) : 356-360.

PDF(1847 KB)
PDF(1847 KB)
Chinese Journal of Contemporary Pediatrics ›› 2014, Vol. 16 ›› Issue (4) : 356-360. DOI: 10.7499/j.issn.1008-8830.2014.04.009
CLINICAL RESEARCH

Significance of serum cholesterol and fibrinogen in evaluating the risk of glomerulosc-lerosis in children with nephrotic syndrome

  • ZHANG Jian-Jiang, FU Shu-Qin, DOU Wen-Jie, SHI Pei-Pei, WANG Miao, TIAN Xi-Yan
Author information +
History +

Abstract

Objective To investigate the significance of serum cholesterol and fibrinogen (Fib) in evaluating the risk of glomerulosclerosis in children with nephrotic syndrome. Methods Sixty-three children with primary nephrotic syndrome were divided into two groups according to their pathological types: minimal change glomerulopathy (MCG) (n=39) and focal segmental glomerulosclerosis (FSGS) groups (n=24). Serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), non-HDL-C and Fib and 24-hour urinary protein excretion were retrospectively analyzed. Results Serum levels of TC, non-HDL-C, and LDL-C were significantly higher in the FSGS group than in the MCG group (P<0.05), but there were no significant differences in HDL-C, Fib and 24-hour urinary protein excretion between the two groups (P>0.05). According to the results of logistic regression analysis, high levels of LDL-C, non-HDL-C and TC were risk factors for FSGS (P<0.05). In patients whose proteinuria did not disappear after taking enough glucocorticoid for 4 weeks, the level of non-HDL-C was significantly higher in the FSGS group than in the MCG group (P<0.05); there were no significant differences in TC, LDL-C, HDL-C, and Fib between the MCG and FSGS groups (P>0.05). Conclusions Serum cholesterol, especially non-LDL-C, is of great significance in evaluating the risk of glomerulosclerosis in children with nephrotic syndrome. There is no sufficient evidence to support serum Fib as a marker for predicting glomerulosclerosis in these children.

Key words

Cholesterol / Fibrinogen / Glomerulosclerosis / Child

Cite this article

Download Citations
ZHANG Jian-Jiang, FU Shu-Qin, DOU Wen-Jie, SHI Pei-Pei, WANG Miao, TIAN Xi-Yan. Significance of serum cholesterol and fibrinogen in evaluating the risk of glomerulosc-lerosis in children with nephrotic syndrome[J]. Chinese Journal of Contemporary Pediatrics. 2014, 16(4): 356-360 https://doi.org/10.7499/j.issn.1008-8830.2014.04.009

References

[1] Gyebi L, Soltani Z, Reisin E. Lipid nephrotoxicity: new concept for an old disease[J]. Curr Hypertens Rep, 2012, 14(2): 177-181.
[2] 李建斋, 王抒, 曾平. 非高密度脂蛋白胆固醇用于评估及预测冠心病危险[J]. 中华心血管病杂志, 2004, 32(11): 963-966.
[3] D'Agati VD, Fogo AB, Bruijn JA, et a1. Pathological classification of focal segmental glomeruloscleresis: a working proposal[J]. Am J Kidney Dis, 2004, 43(2): 368-382.
[4] 中华医学会儿科学分会肾脏病学组. 儿童常见肾脏疾病诊治循证指南(一):激素敏感、复发/依赖肾病综合征诊治循证指南(试行)[J]. 中华儿科杂志, 2009, 47(3): 167-170.
[5] 卫敏江, 吴伟岚, 陈敏怡. TGF-β与肝细胞生长因子在儿童原发性局灶节段性肾小球硬化肾组织中的表达[J]. 中国当代儿科杂志, 2010, 12(8): 630-633.
[6] Saito T. Abnormal lipid metabolism and renal disorders[J]. Tohoku J Exp Med, 1997, 181(3): 321-337.
[7] 陈涛. 糖尿病、心脑血管病和肾病综合征患者脂质代谢水平测定及临床意义[J]. 医学检验与临床, 2004, 1(2): 67-68.
[8] 苏华, 付玲, 刘建社, 等. ATP结合元件A1与肾间质泡沫细胞形成、小管间质损害及血清胆固醇的相关性[J]. 中华肾脏病杂志, 2011, 27(11): 819-824.
[9] 陈丹, 陈燕, 曾彩虹, 等. 肾小球疾病患者肾间质泡沫细胞的分布及意义[J]. 肾脏病与透析肾移植杂志, 2006, 15(4): 322-328.
[10] 李晓忠. 肾脏纤维化能逆转吗?[J]. 实用儿科临床杂志, 2011, 26(17): 1305-1307.
[11] Lee HS. Mechanisms and consequences of hypertriglyceridemia and cellular lipid accumulation in chronic kidney disease and metabolic syndrome[J]. Histol Histopathol, 2011, 26(12): 1599-1610.
[12] 李国璋, 郭海鸽, 郑忠欣, 等. 原发性肾病综合征患者血脂及载脂蛋白的变化[J]. 心脏杂志, 2003, 15(4): 340-341.
[13] Contois JH, Warnick GR, Sniderman AD. Reliability of low-density lipoproteincholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement[J]. J Clin Lipidol, 2011, 5(4): 264-272.
[14] Sniderman AD, Islam S, Yusuf S, et al. Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study[J]. Atherosclerosis, 2012, 225(2): 444-449.
[15] 王明晓, 徐留建, 邹阳春, 等. 非高密度脂蛋白胆固醇的研究进展[J]. 中国心血管病研究, 2010, 8(8): 602-606.
[16] 张婕. 氧化低密度脂蛋白与肾小球硬化的研究进展[J]. 临床儿科杂志, 2011, 29(8): 793-795.
[17] Abate N, Vega GL, Grundy SM. Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100[J]. Atherosclerosis, 1993, 104(1-2): 159-171.
[18] Okwuosa TM, Klein O, Chan C, et al. 13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study[J]. Atherosclerosis, 2013, 226(1): 214-219.
[19] 付强, 周艳玲, 宋晓翔, 等.小剂量肝素联合尿激酶治疗儿童原发性肾病综合征伴高凝状态[J]. 中国当代儿科杂志, 2011, 13(11): 921-922.
PDF(1847 KB)

Accesses

Citation

Detail

Sections
Recommended

/